Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Pluristem Therapeutics Inc.    PSTI   US72940R1023

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/22/2015 05/26/2015 05/27/2015 05/28/2015 05/29/2015 Date
2.85(c) 2.8(c) 2.8(c) 2.8(c) 2.76(c) Last
120 503 126 232 118 532 52 234 37 777 Volume
-0.35% -1.75% 0.00% 0.00% -1.43% Change
More quotes
Financials ($)
Sales 2015 0,38 M
EBIT 2015 -27,1 M
Net income 2015 -26,8 M
Debt 2015 -
Yield 2015 -
Sales 2016 0,30 M
EBIT 2016 -30,2 M
Net income 2016 -29,7 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 512x
Capi. / Sales 2016 647x
Capitalization 197 M
More Financials
Company
Pluristem Therapeutics, Inc. is a bio-therapeutic company, which develops standardized cell therapy products for the treatment of life threatening diseases.The company's patented PLX (PLacental eXpanded) cells drug delivery platform releases a cocktail of therapeutic proteins in response to a... 
More about the company
Surperformance© ratings of Pluristem Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on PLURISTEM THERAPEUTICS INC
05/29 PLURISTEM THERAPEUTICS : VP Karine Kleinhaus, M.D., Radio Guest on June 1, 2015 ..
05/27 PLURISTEM THERAPEUTICS : Regulation FD Disclosure, Financial Statements and Exhi..
05/26 PLURISTEM THERAPEUTICS : Submission of Matters to a Vote of Security Holders (fo..
05/20 PLURISTEM THERAPEUTICS INC. : Pluristem Chosen for Accelerated Marketing Approva..
05/19 PLURISTEM THERAPEUTICS : to Conduct Conference at Tel Aviv Stock Exchange to Rev..
05/18 PLURISTEM THERAPEUTICS : Significant Progress for Pluristem: PLX Cells Were Sele..
05/18 PLURISTEM THERAPEUTICS : Significant Progress for Pluristem: PLX Cells Were Sele..
05/18 PLURISTEM THERAPEUTICS : Significant Progress for Pluristem: PLX Cells Were Sele..
More news
Sector news : Biotechnology & Medical Research - NEC
05/29 GENMAB A/S : Total Number of Voting Rights and Total Share Capital
05/29 ALKERMES : to Present Clinical Data on ALKS 8700 at Annual Meeting of the Consor..
05/29 UNITED THERAPEUTICS : To Present At The Jefferies 2015 Global Healthcare Confere..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
05/28 Pluristem's PLX Cells Get Green Light For Fast Track Clinical Trials In Europ..
05/18 EMA picks Pluristem's PLX cells for accelerated approval program for critical..
05/18 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
04/09 WHY INVESTORS SHOULDN'T WORRY ABOUT : Maxim's Jason Kolbert
03/24 Pluristem details development plan for second cell product


Comments 
Advertisement
Chart PLURISTEM THERAPEUTICS INC
Duration : Period :
Pluristem Therapeutics Inc Technical Analysis Chart | PSTI | US72940R1023 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions